---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-028151"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2025-02-18T23:59:59+00:00"
generated_at: "2026-05-26T13:53:21.346702+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics raises ~$3.7M in secured convertible notes, exchanges warrants, and receives $2M CPRIT advance

## Summary
- Issued $3.36M in secured convertible notes and warrants to purchase ~3M shares at $1.12; aggregate proceeds ~$3.7M.
- Exchanged $3.19M of existing Series A warrants for new secured convertible exchange notes.
- Notes mature Feb 2026, 10% interest, secured by substantially all assets; mandatory conversion if $10M+ qualified financing by March 31, 2025.
- Received $2.0M advance from CPRIT as part of existing $17.6M grant.
- Registration rights with liquidated damages of 1%/month (12% cap) for filing/effectiveness delays.

## SEC filing metadata
- accession: 0001193125-25-028151
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2025-02-18T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312525028151/0001193125-25-028151-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312525028151/d916701d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-028151
- JSON: https://secwatch.observer/filing/0001193125-25-028151.json
- Plain text: https://secwatch.observer/filing/0001193125-25-028151.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.